Article
Two successful pregnancies and first use of empagliflozin during pregnancy in glycogen storage disease type Ib
18 May 2022
Abstract excerpt
. GSD Ib is characterized by hepatomegaly, recurrent hypoglycemia, neutropenia, and neutrophil dysfunction. Only seven pregnancies in four women with GSD Ib have been reported so far. We report on two further successful pregnancies in two patients with GSD Ib. One of these pregnancies was managed with empagliflozin, an SGLT2 inhibitor, repurposed for the treatment of neutropenia in GSD Ib. Both pregnancies were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
